ML329 is a potent small molecule inhibitor that selectively targets the microphthalmia-associated transcription factor (MITF), thereby suppressing its activity on downstream promoters such as TRPM-1. This compound is a valuable research tool for investigating MITF-dependent pathways in melanoma and pigmentation studies, applicable in both in vitro cellular assays and in vivo model systems.
Molekulargewicht:
328.34
Reinheit:
>99.99% (May vary between batches)
CAS Nummer:
[19992-50-8]
Formel:
C16H12N2O4S
Target-Kategorie:
TRP/TRPV Channel,Others
Anwendungsbeschreibung:
Solubility: DMSO:10 mg/mL (30.46 mM)
* Mehrwertsteuer und Versandkosten nicht enthalten. Irrtümer und Preisänderungen vorbehalten